Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It must be given as a subcutaneous injection just under the skin at a dose of 225 mg monthly or 675 mg quarterly.from Medindia Latest Updates https://ift.tt/2xrZyCl
No comments:
Post a Comment